Characterization of naturally occurring protease inhibitor-resistance mutations in genotype 1b hepatitis C virus patients

被引：0
|
作者：
Hiroko Shindo
Shinya Maekawa
Kazuki Komase
Ryota Sueki
Mika Miura
Makoto Kadokura
Kuniaki Shindo
Fumitake Amemiya
Takatoshi Kitamura
Yasuhiro Nakayama
Taisuke Inoue
Minoru Sakamoto
Shun-ichi Okada
Yasuhiro Asahina
Namiki Izumi
Masao Honda
Shuichi Kaneko
Nobuyuki Enomoto
机构：
[1] University of Yamanashi,First Department of Internal Medicine
[2] Musashino Red Cross Hospital,Division of Gastroenterology and Hepatology
[3] Kanazawa University Graduate School of Medicine,Department of Gastroenterology
来源：
Hepatology International | 2012年 / 6卷
关键词：
HCV; Protease inhibitor; Naturally occurring viral resistance mutations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：482 / 490
页数：8
相关论文
共 50 条
  • [31] Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors
    Pham, Long V.
    Ramirez, Santseharay
    Carlsen, Thomas H. R.
    Li, Yi-Ping
    Gottwein, Judith M.
    Bukh, Jens
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [32] All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
    Manns, Michael
    Pol, Stanislas
    Jacobson, Ira M.
    Marcellin, Patrick
    Gordon, Stuart C.
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Everson, Gregory T.
    Heo, Jeong
    Gerken, Guido
    Yoffe, Boris
    Towner, William J.
    Bourliere, Marc
    Metivier, Sophie
    Chu, Chi-Jen
    Sievert, William
    Bronowicki, Jean-Pierre
    Thabut, Dominique
    Lee, Youn-Jae
    Kao, Jia-Horng
    McPhee, Fiona
    Kopit, Justin
    Mendez, Patricia
    Linaberry, Misti
    Hughes, Eric
    Noviello, Stephanie
    LANCET, 2014, 384 (9954): : 1597 - 1605
  • [33] Prediction of Response to Peginterferon-Alfa-2b Plus Ribavirin Therapy in Japanese Patients Infected With Hepatitis C Virus Genotype 1b
    Hashimoto, Yoshimasa
    Ochi, Hidenori
    Abe, Hiromi
    Hayashida, Yasufumi
    Tsuge, Masataka
    Mitsui, Fukiko
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Hayes, C. Nelson
    Ohishi, Waka
    Kubo, Michaki
    Tsunoda, Tatsuhiko
    Kamatani, Naoyuki
    Nakamura, Yusuke
    Chayama, Kazuaki
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (06) : 981 - 988
  • [34] Diagnosis of hepatitis C virus genotype 2k/1b needs NS5B sequencing
    De Keukeleire, Steven
    Descheemaeker, Patrick
    Reynders, Marijke
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 41 : 1 - 2
  • [35] Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir
    De Meyer, Sandra
    Ghys, Anne
    Dierynck, Inge
    Beumont, Maria
    Luo, Donghan
    Picchio, Gaston
    VIROLOGY JOURNAL, 2014, 11
  • [36] Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage
    Hostager, Reilly
    Ragonnet-Cronin, Manon
    Murrell, Ben
    Hedskog, Charlotte
    Osinusi, Anu
    Susser, Simone
    Sarrazin, Christoph
    Svarovskaia, Evguenia
    Wertheim, Joel O.
    VIRUS EVOLUTION, 2019, 5 (02)
  • [37] Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection
    Ohya, Kazuki
    Kawaoka, Tomokazu
    Imamura, Michio
    Morio, Kei
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Hiramatsu, Akira
    Tsuge, Masataka
    Aikata, Hiroshi
    Chayama, Kazuaki
    INTERNAL MEDICINE, 2020, 59 (07) : 941 - 944
  • [38] Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b
    Chida, Takeshi
    Kawata, Kazuhito
    Ohta, Kazuyoshi
    Matsunaga, Erika
    Ito, Jun
    Shimoyama, Shin
    Yamazaki, Satoru
    Noritake, Hidenao
    Suzuki, Tetsuro
    Suda, Takafumi
    Kobayashi, Yoshimasa
    GUT AND LIVER, 2018, 12 (02) : 201 - 207
  • [39] Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct-acting antiviral therapies
    Yoneyama, Hirohito
    Morishita, Asahiro
    Iwama, Hisakazu
    Fujita, Koji
    Masaki, Takahiro
    Tani, Joji
    Tadokoro, Tomoko
    Nomura, Takako
    Sakamoto, Teppei
    Oura, Kyoko
    Takuma, Kei
    Nakahara, Mai
    Mimura, Shima
    Deguchi, Akihiro
    Oryu, Makoto
    Tsutsui, Kunihiko
    Himoto, Takashi
    Shimotohno, Kunitada
    Wakita, Takaji
    Kobara, Hideki
    Masaki, Tsutomu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (04) : 1126 - 1135
  • [40] Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data
    Ishigami, Masatoshi
    Hayashi, Kazuhiko
    Honda, Takashi
    Kuzuya, Teiji
    Ishizu, Yoji
    Ishikawa, Tetsuya
    Nakano, Isao
    Urano, Fumihiro
    Kumada, Takashi
    Yoshioka, Kentaro
    Goto, Hidemi
    Hirooka, Yoshiki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (11) : 1879 - 1886
12345